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Hypoxia, a condition of severe oxygen shortage, induces a transcriptional response that is 
important for both normal embryonic development and the growth of tumors. In this issue, 
Cheng et al. (2007) describe how the stability of the major transcriptional regulator of the 
hypoxic response, HIF1α, is modulated by the interplay between the ubiquitin and the 
SUMO conjugation systems.proteasomal degradation of HIF1α. Posttranslational modifications of pro-
teins by members of the ubiquitin fam-
ily can modulate the properties of pro-
teins in various ways by affecting their 
activity, stability, or interactions with 
other cellular factors. Ubiquitin itself 
is best known as a degradation signal 
when attached to its protein targets as 
a polymeric chain that is recognized by 
the 26S proteasome. The small ubiquit-
in-like modifier SUMO most frequently 
appears to alter protein-protein interac-
tions. Although the ubiquitin and SUMO 
systems rely on independent enzymes 
Figure 1. Coordinating Posttranslational Modifications of HIF1α
The α subunit of the hypoxia-inducible transcription factor (HIF) undergoes multiple posttrans-
lational modifications. Under normoxic conditions, the dioxygenase FIH (factor-inhibiting HIF1) 
hydroxylates an asparagine residue in the carboxy-terminal domain of HIF1α. This prevents in-
teraction with the coactivator p300, thereby reducing the transcriptional activity of HIF on pro-
moters bearing a hypoxia response element (HRE). Hydroxylation by prolyl hydroxylase domain 
(PHD) proteins within the oxygen-dependent degradation (ODD) domain serves as a recognition 
signal for the ubiquitin ligase VHL, resulting in polyubiquitination and degradation by the 26S pro-
teasome. Hypoxia induces SUMOylation of the ODD by the SUMO-conjugating enzyme Ubc9. 
Cheng et al. (2007) now report that VHL also recognizes and ubiquitinates SUMOylated HIF1α. 
However, in the presence of the SUMO-specific isopeptidase SENP1, HIF1α is deSUMOylated, 
escapes degradation, and activates transcription of various genes involved in erythropoiesis, 
angiogenesis, and glucose metabolism.446 Cell 131, November 2, 2007 ©2007 Elsevier Inc.for conjugation and removal, they are 
not blind to each other’s actions, in 
fact, an intriguing number of proteins 
are targeted by both modifiers. In the 
case of the NF-κB inhibitor IκBα and 
the protein huntingtin, ubiquitin targets 
the substrate for degradation, whereas 
SUMO exerts a stabilizing effect. How-
ever, in most cases the relationship 
between ubiquitin and SUMO is more 
complex (Ulrich, 2005). Therefore it 
is crucial to identify the physiologi-
cal signals that trigger each modifica-
tion for a given protein. In this issue of 
Cell, Cheng et al. (2007) provide insight 
into the interplay between ubiquitin 
and SUMO in the cellular response to 
hypoxia, a potentially dangerous con-
dition of reduced oxygen concentra-
tion that requires a drastic adaptation 
of cellular metabolism (Brahimi-Horn et 
al., 2007).
Hypoxic conditions, found in tumors 
as well as during normal embryogene-
sis, activate a transcriptional response 
that promotes vascular development 
and the formation of red blood cells 
(erythropoiesis). The master transcrip-
tional regulator of oxygen-controlled 
gene expression is the hypoxia-in-
ducible factor HIF. HIF consists of two 
subunits, and the activity and stability 
of the α subunit (HIF1α) is subject to 
intricate regulation. At physiological 
levels of oxygen, HIF1α is hydroxylated 
by oxygen-dependent prolyl hydroxy-
lases, allowing an interaction with the 
ubiquitin ligase VHL. This interaction 
leads to rapid polyubiquitination and 
Hydroxylation at an asparagine resi-
due by another dioxygenase prevents 
interaction with the coactivator p300, 
thus reducing HIF1α’s transcriptional 
activity. Hypoxia inhibits the hydroxy-
lases, thereby stabilizing HIF1α in an 
active state (Figure 1).
Previous reports have implicated 
the SUMO system in hypoxia. Expres-
sion of SUMO is upregulated, and 
the modifier directly targets HIF1α 
in response to low oxygen levels 
(Shao et al., 2004). Cheng et al. have 
now identified SENP1 as the SUMO-
specific isopeptidase that is respon-
sible for the removal of SUMO from 
HIF1α. They show that deletion of 
the SENP1 gene in mice results in 
early embryonic lethality caused by 
severe anemia due to lack of HIF- 
dependent erythropoietin production. 
Thus, deSUMOylation appears to be 
necessary for HIF1α activity and/or 
stability. Indeed, the authors found that 
wild-type HIF1α was rapidly degraded 
in mouse embryonic fibroblasts lack-
ing SENP1 even in hypoxic conditions, 
whereas overexpression of SENP1 
markedly enhanced HIF1α activity. 
In contrast, mutant HIF1α that could 
not be SUMOylated was more stable 
and much less affected by the pres-
ence or absence of the isopeptidase. 
Upon inhibition of the proteasome, 
SUMOylated HIF1α accumulated in 
cells lacking SENP1 during hypoxia, 
prompting the authors to examine 
whether SUMOylation might serve 
as a signal for HIF1α ubiquitination. 
Consistent with this model, ubiquit-
inated HIF1α was detected following 
over expression of SUMO, whereas 
over expression of the isopeptidase 
reduced its ubiquitination. Intriguingly, 
the VHL complex, responsible for ubiq-
uitination of prolyl-hydroxylated HIF1α 
under physiological oxygen levels, was 
found to mediate the ubiquitination 
of sumoylated HIF1α as well. In fact, 
Cheng et al. were able to demonstrate 
a direct interaction of the β domain 
of VHL, which acts as a substrate-
binding region, with the SUMOy-
lated but not the unmodified forms of 
HIF1α. Based on these findings, the 
authors propose that SUMOylation of 
HIF1α serves as a direct signal for its 
 ubiquitin-dependent degradation.The notion that SUMO acts as a 
recognition signal for a ubiquitin ligase 
is not without precedent. A number 
of recent publications have reported 
that the yeast RING finger protein Slx8 
and its mammalian homolog RNF4 
mediate ubiquitination of proteins in a 
SUMO-dependent manner (Prudden 
et al., 2007; Sun et al., 2007; Uzunova 
et al., 2007; Xie et al., 2007). Whereas 
Slx8 in budding and fission yeast 
dimerizes with a second RING finger 
protein harboring a SUMO interaction 
motif that is responsible for recogni-
tion of the SUMO moiety, mammalian 
RNF4 combines both properties in a 
single polypeptide. Taken together, 
these reports strongly suggest that 
in addition to acting in opposition, 
ubiquitin and SUMO may sometimes 
cooperate toward a common goal.
In the context of hypoxia, many 
important questions regarding the 
function of SUMOylation and deSU-
MOylation remain unanswered. The 
findings described here (Figure 1) 
stand in contrast to previous studies 
implicating SUMO in the activation 
of transcription through HIF1α sta-
bilization (Bae et al., 2004; Carbia-
Nagashima et al., 2007). Indeed, Car-
bia-Nagashima et al. (2007) recently 
described in Cell a new hypoxia-in-
duced protein, RSUME, whose over-
expression enhances SUMO con-
jugation and has a stabilizing effect 
on HIF1α. According to this report, 
RSUME promotes SUMOylation by 
enhancing its activation via thioester 
formation, but it also interacts with 
several known SUMO substrates such 
as IκBα and HIF1α, suggesting that it 
is directly involved in the conjugation 
reaction. Yet another study reported 
that hypoxia-induced SUMOylation 
of HIF1α reduces its transcriptional 
activity without affecting its half-life 
(Berta et al., 2007).
In their new work, Cheng et al. 
have convincingly shown that the 
deSUMOylating activity of SENP1 is 
required for HIF-dependent transcrip-
tion during embryogenesis; however, 
their model invoking SENP1-medi-
ated stabilization of HIF1α does not 
explain how or why the protein is 
subject to hypoxia-induced SUMOy-
lation at all. A requirement for con-Cell 131, Nosecutive SUMOylation and deSU-
MOylation events would solve this 
puzzle if SUMO conjugation were 
involved in the translocation of HIF1α 
into the nucleus; however, the authors 
claim that this is not the case. It also 
remains to be determined how VHL 
recognizes the SUMOylated form of 
HIF1α when it normally binds to the 
hydroxylated form. Finally, it appears 
as if additional modifications, such as 
acetylation and phosphorylation, and 
other ubiquitin ligases may also influ-
ence the activity and stability of HIF1α 
(Brahimi-Horn et al., 2007). These 
notions suggest that multiple regula-
tory pathways converge to control key 
modulators of cellular metabolism, 
such as HIF1α, and much additional 
work will be required to elucidate their 
mechanisms and interdependencies.
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